Chlorine in PDB 6pno: Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide

Enzymatic activity of Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide

All present enzymatic activity of Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide:
1.20.4.2; 1.8.5.1; 2.5.1.18;

Protein crystallography data

The structure of Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide, PDB code: 6pno was solved by A.J.Oakley, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 40.50 / 1.82
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 57.260, 57.260, 139.991, 90.00, 90.00, 120.00
R / Rfree (%) 19.4 / 23.8

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide (pdb code 6pno). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide, PDB code: 6pno:

Chlorine binding site 1 out of 1 in 6pno

Go back to Chlorine Binding Sites List in 6pno
Chlorine binding site 1 out of 1 in the Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Human GSTO1-1 Complexed with 2-Chloro-N-(4-Chloro-3-(N- Isopropylsulfamoyl)Phenyl)Acetamide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1001

b:50.0
occ:0.88
 CLA A:ORM1001 0.0 50.0 0.9
CAF A:ORM1001 1.6 41.8 0.9
CAA A:ORM1001 2.5 42.6 0.9
CAE A:ORM1001 2.6 42.7 0.9
NAL A:ORM1001 3.1 48.6 0.9
SAI A:ORM1001 3.2 43.2 0.9
OAK A:ORM1001 3.2 45.3 0.9
CAO A:ORM1001 3.4 55.2 0.9
CA A:GLY128 3.4 26.1 0.5
CAM A:ORM1001 3.7 53.4 0.9
O A:HOH1104 3.8 29.1 1.0
CAB A:ORM1001 3.8 39.0 0.9
CAD A:ORM1001 3.8 39.3 0.9
N A:GLY128 4.2 25.0 0.5
CAC A:ORM1001 4.3 38.9 0.9
CG1 A:VAL127 4.3 28.5 0.5
CAN A:ORM1001 4.4 53.7 0.9
N A:GLY128 4.4 31.0 0.5
CB A:VAL127 4.6 28.1 0.5
C A:GLY128 4.6 27.6 0.5
OAJ A:ORM1001 4.6 41.8 0.9
O A:PRO124 4.7 25.6 1.0
C A:VAL127 4.7 30.4 0.5
CA A:GLY128 4.8 32.1 0.5
O A:GLY128 4.8 28.8 0.5

Reference:

Y.Xie, P.Tummala, A.J.Oakley, G.S.Deora, M.Rooke, M.E.Cuellar, J.M.Strasser, J.L.Dahlin, M.A.Walters, M.G.Casarotto, P.G.Board, J.B.Baell. Development of Benzenesulfonamide Derivatives As Potent Glutathione Transferase Omega-1 Inhibitors To Be Published.
Page generated: Sat Dec 12 13:31:01 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy